What makes chondrocytes special?  by Hardingham, T.
Abstracts / Osteoarthritis and Cartilage 20 (2012) S1–S9 S5Generally, conservative management options should be exhausted prior
to consideration of surgical intervention. Young patients with large
defects present a potential exception to this recommendation, since
lesion growth can occur evenwith symptomatic improvement from non-
operative treatment, potentially worsening the structural problem. For
example, the majority of young patients experience almost complete
resolution of knee pain after removal of a loose osteochondritis dissecans
(OCD) fragment. However, if the defect is left empty, 50% to 80% will
develop radiographic evidence of osteoarthritis after 8 to10 years. This is
the patient population where cartilage repair is deemed most beneﬁcial,
in hopes of slowing the progression of degenerative changes.
Cartilage damage encompasses a wide spectrum ranging from focal
chondral defects all the way to tricompartmental osteoarthritis. While
the latter is beyond the capabilities of current cartilage repair proce-
dures, earlier stages in the disease process can be managed successfully
with cartilage repair. Historically, attempts at cartilage repair tended to
focus on the defect itself; often disregarding articular co-morbidities,
such asmalalignmentormeniscal deﬁciency, thatwere the root cause for
the development of cartilage damage in the ﬁrst place. Not surprisingly,
early reports of cartilage repairwere disappointing;more recent studies,
however, have shown success in over 70 to 80% of patients. This
substantial improvement has been attributed to the increased recogni-
tion and treatment of articular co-morbidities concurrently with carti-
lage repair in a process termed biologic joint reconstruction.
Cartilage repair options are chosen depending on defect location and
size. Generally, smaller defects (<2–3 cm2) are amendable to minimally
invasive procedures such as marrow stimulation and osteochondral
autograft transfer (also known as OATS or Mosaicplasty). Larger defects
have demonstrated disappointing outcomes with these procedures, and
are therefore mostly treated with cell-based therapy utilizing autolo-
gous chondrocytes or osteochondral allograft transplantation. Several
new implants are currently under development, and synthetic plugs
have received increased attention in hopes of providing a cost-efﬁcient,
off-the shelf option.
However, careful attention is required to correctly identify and address
the frequently present co-morbidities involved in the degenerative
disease process, such as malalignment and meniscal deﬁciency. The
concurrent use of osteotomy and meniscal transplantation is common
and necessary to normalize the biomechanical environment.
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EPIGENETICS: MARKS FOR FUTURE OA RESEARCH?
D.A. Young, M.J. Barter, C. Bui. Newcastle Unversity, Newcastle upon Tyne,
United kingdom
Purpose: Osteoarthritis (OA) is a complex multifactorial disease.
Several studies have suggested or identiﬁed epigenetic events, which
include DNA methylation, histone modiﬁcations, and microRNAs, that
may play a role in OA progression and the gene expression changes
observed in diseased cartilage. Collectively epigenetic modiﬁcations
allow the cell to respond quickly to environmental changes and these
can be inherited during cell division. However, aberrant epigenetic
modiﬁcations are associated with a number of pathological conditions,
including OA. The aim of this talk is to inform about current research in
epigenetics and epigenetics in OA. DNA methylation and chromatin
changes in OA are currently understudied, with most work focussing on
microRNAs which clearly have a role in skeletal development. Recent
advancements in epigenetic research suggest that global analysis of
suchmodiﬁcations in OA are now possible, however, with the exception
of microRNAs, it will be a signiﬁcant challenge to demonstrate how such
modiﬁcations impact on the disease or how they could be readdressed
to limit disease progression.
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OSTEOARTHRITIS IS AN INFLAMMATORY DISEASE
F. Berenbaum, Sr.1,2. 1 Pierre & Marie Curie Univ., paris, France; 2AP-HP
Saint-Antoine Hosp., Paris, France
Osteoarthritis (OA) has long been considered as a “tear-and-wear”
process. In the last 15 years, the face of OA has deeply changed, now
considered as a disease involving all tissues of a joint eventually leading
to cartilage degradation. Among these tissues, a particular attention has
been recently paid on the role of synovium in the OA process. A patchy
inﬂammation of this tissue is described, with some kind of correlation
between the degree of the synovitis and the prognostic of the disease.Whether this synovitis is a primummovens of the process or secondary
to a reaction to cartilage fragments falling into the joint remains
debated. Many inﬂammatory mediators belonging to the cytokine
family, to inﬂammatory lipid mediators, or to matrix components play
a critical role in the OA process. Interestingly, the source of these soluble
mediators may be the chondrocytes themselves (via autocrine/para-
crine loops), the synovial cells and the subchondral bone cells. Inter-
estingly, all the risk factors playing a role in OA have a potential to
increase the release of inﬂammatory mediators into the joints (adipo-
kines for obesity/metabolic syndrome, secretory proﬁle of senescent
chondrocytes, synovitis in post-trauma). The most recent studies
highlight the possibility of cross-talks between joint cells leading to
communication of mediators within and between the tissues of a joint.
Finally, the paradigm based on a mechanical-driven origin of the
disease is not conﬂictual with the inﬂammatory hypothesis since
mechanical signals are shifted into biochemical signals in chondrocytes
and subchondral bone cells via mechanoreceptors leading to the release
of pro-degradative and pro-inﬂammatory mediators.
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CHALLENGES IN STUDYING RISK FACTORS FOR OA PROGRESSION
Y. Zhang. Boston Univ., Boston, MA
Purpose: While several risk factors have been indentiﬁed for incident
radiographic knee osteoarthritis (ROA), ﬁndings on risk factors, espe-
cially chronic ones, for progression of ROA have been inconclusive. Some
factors that increase the risk of incident kneeROAhavean opposite effect
on ROA progression. The reasons for such a paradoxical phenomenon
have not been scrutinized. We explored several explanations that may
underlie thediscrepancybetweenﬁndings for kneeROAprogression and
those for knee ROA incidence using causal diagrams and real data, when
available. First, in observational studies of knee ROA progression
conditioning on (or limiting to) subjects who already have mild or
moderate disease will block the causal pathway between the risk factor
of interest, which often occurs prior to the occurrence of ROA, and ROA
progression; consequently it completely eliminates the effect of the risk
factor on OA progression. Second, conditioning on preexisting disease
will likely induce a negative correlation between the factor of interest
and potential confounders; such bias tends to dilute effect estimates.
Third, most studies of ROA progression often have followed participants
over a long period of time. If a substantial proportion of subjects are lost
to follow-up, the resulting selection bias can alter the effect estimate.
Finally, knees that progress toend stageduring the long interval between
imaging assessments will be treated the same at the end of the study
regardless of when they reached that stage; thus, the ceiling effects and
the relatively insensitive measures used to assess ROA progression will
make the effect estimate close to the null value. In conclusion, meth-
odological challenges in observational studies of risk factors for ROA
progression, especially chronic factors, are difﬁcult to overcome. Novel
study design and analytic approaches for ROA progression are required
to address these issues.
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WHAT MAKES CHONDROCYTES SPECIAL?
T. Hardingham. Univ. of Manchester, Manchester, United kingdom
Cartilage consists of a dense network of collagen ﬁbres embedded in an
aggrecan gel, within which is a sparse population of cells, the chon-
drocytes. Cartilage is tough and resilient and the matrix is dense and
does not allow migration or trafﬁcking of cells. The collagen and
aggrecan are of extremely slow turnover and the load bearing proper-
ties of cartilage depend on its physical integrity and cohesive structure.
Chondrocytes thus live within a special environment, which they are
responsible for assembling during development and maintaining
throughout life. Chondrocytes in adult cartilage thus lead a lonely
existence over many decades and the ageing of chondrocytes may be
a signiﬁcant factor in chondrocyte biology and pathology.
Cartilage chondrocytes are needed throughout life to make, repair and
remodel matrix. To carry out this function chondrocyte respond to
a whole range of physical and biochemical signals that guide the
balance of their activities. This includes paracrine and autocrine effects
of growth factors, cytokines and chemokines and the biomechanical
signals from tensile and compressive loading acting through cell matrix
interactions and accompanying ionic and osmotic ﬂuxes. These
processes require the co-ordinated activity of many different pathways
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a healthy cartilage tissue requires the sustained function of many
cellular processes and any decline in performance may weaken the
tissue and lead to pathology. These changes may arise because of
inherited susceptibilities and their interaction with environmental
challenges, such as trauma, obesity and ageing.
There is much evidence that many changes occur in chondrocytes
during ageing. In OA there is evidence of an age-related increase in ER
stress, which may mark a decline in secretary pathway function in
chondrocytes and could restrict their ability to maintain the tissue.
There is also evidence of increased apoptosis in OA, which may suggest
that there is an age-related decline in chondrocyte threshold for
survival. This may extend to pathways, such as those involving DNA
repair, resistance to oxidative stress, which may result in accumulated
DNA and protein damage. It may also apply to new areas of chondrocyte
biology, such as circadian clock genes, which have been detected in
chondrocytes (Boot-Handford, Qing-jun Meng, personal communica-
tion). Many circadian clocks in other biological systems show age-
related changes and such changes in chondrocytesmay lead to impaired
function. Any of these factors may be potentially damaging, because in
cartilage, in contrast with most other tissues, there are no means by
which dead or poorly performing cells can be replaced. It is this feature
that makes chondrocytes special and cartilage the tissue in the joint
most at risk of irreversible damage and loss.
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NEW GENOMIC TECHNOLOGIES FOR THE STUDY OF OA
I. Meulenbelt. LUMC, Leiden, Netherlands
Osteoarthritis (OA) is a prevalent, disabling joint disease with a consider-
able, but complex, genetic component. In order to dissect underlying
mechanisms of OA, many researchers have applied genetic genome wide
approaches or, to explore the dynamic state ofOA affected cartilage,micro
arrayRNAexpressionproﬁling. Althoughrobustﬁndingshavebeen found,
major challenges remain; current OA susceptibility SNPs explain only
a small part of the heritability, whereas, micro-array expression tech-
niques have shown to have onlya limited ability to catalogue and quantify
the transcriptome. Given the small attributable risk of current OA
susceptibility SNPs, researchers have come to the presumption that there
may be many, yet undetected, rare variants and/or unconsidered non-
genetic variation that could inﬂuence the complex etiology of OA.
The introduction of high-throughput next generation sequencing
technologies has revolutionized both genomic and transcriptomic
research. It allows whole genome and exome DNA sequencing in
addition to sensitive RNA analyses through cDNA sequencing. As such, it
eliminates a large part of the posed challenges. Considering the non-
genetic variation, especially the epigenetic variation appears to be
relevant. Epigenetic marks as reﬂected by methylation of cytosine's in
cytosine-guanine (CpG) dinucleotides are involved in processes that
require a stable control of gene expression or a selective gene-silencing.
Loss of epigenetic control may result in differential gene expression and
may underlie complex traits. Up until now, however, the studies aiming
to explore these non-genetic variations were performed with inade-
quate genome coverage or failed to measure in the relevant (diseased)
tissue. Recently for DNA methylation, a new technology has become
available that allows high throughput typing of around 500,000
metylation sites, covering around 99 percent of RefSeq genes.
Together, these new genomic technologies may provide important
additional biological insights into molecular and cellular events
commencing OA onset.
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CLINICAL PAIN SEVERITY AND EXPERIMENTAL PAIN SENSITIVITY IN
OSTEOARTHRITIS
Y.C. Lee. Brigham and Women's Hosp., Boston, MA
Pain is the most common presenting symptom of osteoarthritis and an
important outcome in most osteoarthritis intervention trials. However,
the causes of pain among osteoarthritis patients are not well-under-
stood, and studies of pain mechanisms have been limited. To date, most
studies have relied on visual analog scales of overall pain or patient-
reported pain at joint sites, but these measurements are subjective and
prone to bias. Although osteoarthritis is often deﬁned structurally by
cartilage loss and joint space narrowing, population-based studies have
indicated that the association between joint space narrowing andpatient-reported pain is weak. Recent studies, however, suggest that
correlations between structural changes and pain may be masked by
other factors, such as central pain processing mechanisms, which differ
between patients. To examine pain mechanisms, some studies have
utilized quantitative sensory testing techniques, which rely on the
application of deﬁned, noxious, experimental stimuli to determine pain
threshold and tolerance levels. These studies suggest that, compared to
pain-free controls, osteoarthritis patients are more sensitive to exper-
imental noxious stimuli at both joint and non-joint sites, indicating
diffuse hyperalgesia, characteristic of central pain syndromes. Studies
using quantitative sensory testing methods and functional neuro-
imaging have also indicated that osteoarthritis patients have impair-
ments in conditioned pain modulation, also known as descending
analgesia or diffuse noxious inhibitory controls. This talk will give an
overview of the study of pain mechanisms in osteoarthritis, focusing on
studies of experimental pain sensitivity in osteoarthritis patients, and
the implications of these studies for future research and for the
development of pain management strategies in osteoarthritis.
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NEW GUIDELINES ON PUBLISHING ANIMAL STUDIES
C.B. Little. Kolling Inst. of Med. Res., Univ. of Sydney, St Leonards, Australia
Animal models are powerful research tools that provide a critical step
not only in furthering our understanding of disease pathogenesis and
potential therapeutic intervention, but also they contribute signiﬁcantly
to the “translatability” of drug discovery projects toward clinical reali-
zation. It is scientiﬁcally incumbent upon researchers to ensure that
their experiments are well designed, controlled, powered, analyzed and
reported. In the case of research involving animal models, this is true
not only from the perspective of good scientiﬁc practice but also to
fulﬁll our responsibility for the appropriate and ethical use of animals
i.e. implementing the “3Rs”. A critical component of reduction and
reﬁnement is ensuring that animal studies are appropriately planned,
evaluated, and reported. Poor reporting is as problematic as poor
experimental design in diminishing the value and validity of any
scientiﬁc research. Recent reviews have highlighted the deﬁciencies in
reporting in many studies using animal models for a variety of diseases,
and those for osteoarthritis (OA) are no exception.
The ARRIVE guidelines were developed to provide a comprehensive
checklist (20 items) for authors to follow (1), and their use is now
a recommendation for submission of such manuscripts to OA&C.
Although the emphasis is on “reporting”, the ARRIVE and other
guidelines, should be consulted BEFORE embarking on a study using
animals, to ensure researchers control for factors that can signiﬁcantly
alter the experimental outcomes, and hamper or even invalidate the
interpretation of the data. While applicable to all animal-based studies,
the present workshop will highlight and discuss the importance of the
ARRIVE guidelines as they speciﬁcally relate to OA research (2). Addi-
tionally speciﬁc issues in statistical analysis of animal studies (e.g. small
“n”, ordinal data etc) will be reviewed. In the long term, use of these
guidelines will promote more consistent publication of animal studies,
ultimately enabling better comparisons between laboratories and
systematic reviews of the literature.
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STATE OF ART IN MANAGING HAND OSTEOARTHRITIS
L. Punzi, P. Frallonardo, C. Campana, R. Ramonda. Rheumatology Unit,
Univ. of Padova, Padova, Italy
Hand osteoarthritis (HOA) is a common disorder frequently causing
pain and impaired function with subsequent reduction in health-
related quality of life. Compared to other OA localisations, the
management of HOA may be sometimes difﬁcult, due to its great
heterogeneity. The treatment may be inﬂuenced by many factors,
